FDA Inspection 906221 — Kryolan GmbH

Kryolan GmbH — FEI 1000161942

The FDA completed an inspection of Kryolan GmbH on Nov 14, 2014 in Berlin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 14, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Berlin (Germany)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
136121 CFR 211.100(a)Absence of Written Procedures
162621 CFR 211.130Procedures are written, and followed
178721 CFR 211.80(a)Procedures To Be in Writing
181021 CFR 211.160(a)Lab controls established, including changes
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
900121 CFR 211.22(a)Lack of quality control unit

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.